Medicine
Elitek kit
Elitek kit is a prescription medicine containing Rasburicase, marketed by Sanofi-Aventis, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Do not freeze. The lyophilized drug product and the diluent for reconstitution…
Key facts
- Active ingredient (INN)
- Rasburicase
- Brand
- Elitek
- Dosage form
- Kit
- Packs
- 3 kits, 1 kit
- Marketing authorisation holder
- Sanofi-Aventis
- Manufacturer
- Sanofi-Aventis
- Origin register
- US FDA, United States
- Storage
- Do not freeze. The lyophilized drug product and the diluent for reconstitution should be stored at 2°C-8°C (36°F-46°F). Protect from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AF07 Rasburicase
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 July 2002
- Identifiers
- RxCUI 1790344, 1790347, 1790349 +1DailyMed set ID 0ae10bc4-6b65-402f-9db5-2d7753054922NDC 0024-5150, 0024-5151Application BLA103946
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 3 kit in 1 carton / 1 kit in 1 kit * 1 mL in 1 vial, single-use * 1 mL in 1 ampule | 0024-5150-10 | Sanofi-Aventis | 12 July 2002 |
| 1 kit in 1 carton * 5 mL in 1 vial, single-use * 5 mL in 1 ampule | 0024-5151-75 | Sanofi-Aventis | 1 June 2006 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Rasburicase is a prescription medicine indicated for the initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies, among other approved uses. It is available as kits. MedsAcross supplies Rasburicase for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RasburicaseFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Elitek prescribing information (Sanofi-Aventis) · U.S. National Library of Medicine, DailyMed
- Fasturtec: European public assessment report (EPAR) · European Medicines Agency
Need Elitek kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.